APA / OTS

Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners. Its moss-based platform is ideally suited to produce difficult-to-express but therapeutically promising drug candidates.

- Lightweight design and alternative drives go hand in hand,
- Structural lightweight design complements existing product portfolio.

Syntellix CEO Claassen: "Greatest and most important success in the company's history".

High-quality recycling starts with targeted collection.

Plastic fingers are known to be able to outsmart many fingerprint scanners. Therefore, special hardware and software have since been developed to prevent cases of such counterfeit. The LivDet competition compares the efficiency of these detection methods. The software of the German company DERMALOG is again number 1 in protecting identification systems against fake fingerprints.

FDI World Dental Federation (FDI) releases new educational resources to mark World Smile Day®.

• 1NCE will use the $50M in funding to accelerate its growth in the US and Asia.

• The capital raised will also be used to further developing 1NCE's next level and cloud-based IoT-software.

• 1NCE will be hiring top talent and industry experts to drive its expansion.

When: October 5, 2021, 15:30-16:00

Where: TOMRA, Otto-Hahn-Straße 2-6, 56218 Mülheim-Kärlich

We are excited to invite representatives of the media to TOMRA headquarters in Mülheim-Kärlich on October 5th (in-person, or online) for a press conference with our new president and CEO, Tove Andersen.